Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001450324-17-000001
Filing Date
2017-04-11
Accepted
2017-04-11 09:54:55
Documents
1
Period of Report
2017-04-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3006
  Complete submission text file 0001450324-17-000001.txt   4438
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Issuer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 4649 PONCE DE LEON BLVD. #495 CORAL GABLES FL 33146
Business Address
Equels Thomas K. (Reporting) CIK: 0001450324 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27072 | Film No.: 17755071